IBIvan Bambir

Ivan Bambir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ivan Bambir has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia

    by Lora Stanka Kirigin Biloš, Maja Baretić, Andrea Vukić Dugac, Krešimir Schoenwald, Ivan Bambir, Duška Tješić Drinković, Nevena Krnić, Velimir Altabas

    This study investigated the prevalence of cystic fibrosis-related diabetes (CFRD) in the Croatian cystic fibrosis (CF) population, the age at diagnosis, insulin requirements, and the relationship between age at diagnosis and other clinical parameters. Medical records from 152 patients with genetically and laboratory-confirmed CF were reviewed through to 2025. The American Diabetes Association criteria were used to diagnose CFRD. Anthropometric and clinical data were collected from the latest medical records. A total of 17 out of 152 patients had CFRD, with a prevalence of 4.8% in the paediatric population (4/84) and 19.1% in adults (13/68). The median age of CFRD diagnosis was 14 years (range 9–22 years, SD = 3.95). Thirteen patients used insulin: one used bolus only, seven used basal-bolus multiple daily injections, and five used insulin pumps. The average total daily insulin (TDI) per kilogram (kg) body weight was 0.447 U/kg (SD = 0.429). The age at CFRD diagnosis was positively correlated with the body mass index (BMI) (p = 0.029). Patients requiring insulin by age 15 had higher TDI and were more likely to have CF liver disease (p = 0.027, p = 0.037, respectively). The prevalence of CFRD and age at diagnosis aligned with previous studies. Patients diagnosed at a younger age and requiring insulin earlier had lower BMIs, likely due to a faster decline in beta cell function and earlier onset of insulinopenia.


  • Cystic fibrosis year in review 2024

    by Amel Alameeri, Burcu Capraz Yavuz, Francesca Lucca, Ivan Bambir, Paulina Famulska, Renata Wrobel Folescu Cohen


  • Open Access

    Inhalacijska terapija u djece

    by Ivan Bambir, Nevenka Cigrovski, Drago Ćaleta, Dalibor Šarić, Andrea Vukić Dugac

    Inhalacijska terapija jedan je od stupova liječenja plućnih bolesti. Na dostavu lijeka u pluća utječu anatomija dišnog sustava, fizikalno-kemijska svojstva samog lijeka te čimbenici prijenosa lijeka (sredstva za dostavljanje lijeka, tehnika disanja i...

  • Open Access

    Cystic fibrosis – new therapeutic aproaches

    by Duška Tješić-Drinković, Lana Omerza, Ivan Bambir, Ivana Todorić, Mirna Natalija Aničić, Irena Senečić-Čala, Jurica Vuković, Andrea Vukić Dugac, Dorian Tješić-Drinković

    Uvod: Mongenska autosomno recesivno nasljedna bolest cistična fibroza (CF) prije pedesetak je godina završavala smrću u ranom djetinjstvu. Devedesetih se godina, zahvaljujući simptomatskom liječenju uz strukturiran, sveobuhvatan multidisciplinarni pr...